<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01655433</url>
  </required_header>
  <id_info>
    <org_study_id>VMXP-2490</org_study_id>
    <nct_id>NCT01655433</nct_id>
  </id_info>
  <brief_title>Evaluation of Ultrafast Hypothermia Before Reperfusion in STEMI Patients</brief_title>
  <acronym>VELOCITY</acronym>
  <official_title>VELOCITY: Pilot Study to Evaluate Ultrafast Hypothermia Before Reperfusion in Patients With Acute ST-Elevation Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Velomedix, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Velomedix, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will look at the safety of treating patients with heart attack with mild
      hypothermia induced using a system of automated peritoneal lavage. The hypothesis is that the
      Velomedix Automated Peritoneal Lavage System can treat patients with heart attack safely and
      with adequate performance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study aims to determine the safety and feasibility of using the Velomedix Automated
      Peritoneal Lavage System to treat patients with STEMI using therapeutic hypothermia. Patients
      will undergo cooling, maintenance and rewarming and applicable data will be gathered on
      device performance and patient safety. Patient temperature and vital signs will be monitored
      in addition to various laboratory values. Adverse event reporting will take place at multiple
      time intervals and follow-up will continue out to 6-months.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Sponsor business decision, not safety related
  </why_stopped>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite of new-onset SAEs</measure>
    <time_frame>30 days</time_frame>
    <description>Composite of new-onset serious adverse events, specifically death, ischemia driven target vessel revascularization (TVR), recurrent MI, pneumonia, sepsis, ventricular tachycardia or fibrillation requiring cardioversion, renal failure, peritonitis and significant bleeding.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MACE rate</measure>
    <time_frame>30 days</time_frame>
    <description>MACE (cardiac related mortality, recurrent MI, or ischemia driven target vessel revascularization (PCI or CABG) at 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>6 months</time_frame>
    <description>All cause mortality through 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarct size</measure>
    <time_frame>3 days</time_frame>
    <description>Myocardial infarct size at 3 days post-procedure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>ST-elevation MI</condition>
  <condition>Hypothermia</condition>
  <arm_group>
    <arm_group_label>Therapeutic Hypothermia Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>No Hypothermia Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>control group is no hypothermia treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Velomedix APLS device</intervention_name>
    <description>Velomedix, Automated Peritoneal Lavage System</description>
    <arm_group_label>Therapeutic Hypothermia Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Hypothermia Treatment</intervention_name>
    <arm_group_label>No Hypothermia Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical symptoms consistent with acute STEMI lasting at least 30 minutes

          -  STEMI with ST-Elevation of ≥2 mm in two or more contiguous ECG leads

          -  Patient eligible for PCI

        Exclusion Criteria:

          -  Cardiac arrest with return of spontaneous circulation

          -  Known prior history of MI

          -  Known history of severe COPD requiring supplemental home oxygen

          -  Patient experiencing intractable cardiogenic shock, or requiring immediate placement
             of a mechanical cardiac assist device

          -  Known severe anemia or abnormal platelet count

          -  Known significant renal insufficiency

          -  Known contraindication for MRI

          -  Known contraindications to hypothermia, such as temperature-sensitive hematological
             dyscrasias or vasospastic disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregg Stone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York Presbyterian Hospital / Columbia University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Graham Nichol, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington, Harberview Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heart Center Research, LLC</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LA County USC Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northeast Georgia Medical Center</name>
      <address>
        <city>Gainesville</city>
        <state>Georgia</state>
        <zip>30501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ochsner Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Victoria Heart Institute Foundation</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <zip>VSR 4R2,</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Universitaire de cardiologie et pneumologie de Québec (Hopital Laval)</name>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 30, 2012</study_first_submitted>
  <study_first_submitted_qc>July 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2012</study_first_posted>
  <last_update_submitted>July 24, 2014</last_update_submitted>
  <last_update_submitted_qc>July 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ST-elevation MI</keyword>
  <keyword>Hypothermia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypothermia</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

